- Home
- GTEC vs ABVC Comparison
GTEC vs ABVC Comparison
Compare GTEC & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTEC
- ABVC
- Stock Information
- Founded
- GTEC 2006
- ABVC 2015
- Country
- GTEC United States
- ABVC United States
- Employees
- GTEC N/A
- ABVC N/A
- Industry
- GTEC Industrial Machinery/Components
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- GTEC Industrials
- ABVC Health Care
- Exchange
- GTEC Nasdaq
- ABVC Nasdaq
- Market Cap
- GTEC 18.2M
- ABVC 16.7M
- IPO Year
- GTEC N/A
- ABVC N/A
- Fundamental
- Price
- GTEC $1.90
- ABVC $1.11
- Analyst Decision
- GTEC
- ABVC
- Analyst Count
- GTEC 0
- ABVC 0
- Target Price
- GTEC N/A
- ABVC N/A
- AVG Volume (30 Days)
- GTEC 4.7M
- ABVC 282.7K
- Earning Date
- GTEC 03-26-2025
- ABVC 05-16-2025
- Dividend Yield
- GTEC N/A
- ABVC N/A
- EPS Growth
- GTEC N/A
- ABVC N/A
- EPS
- GTEC 1.03
- ABVC N/A
- Revenue
- GTEC $83,944,661.00
- ABVC $509,788.00
- Revenue This Year
- GTEC N/A
- ABVC N/A
- Revenue Next Year
- GTEC $1.70
- ABVC N/A
- P/E Ratio
- GTEC $1.84
- ABVC N/A
- Revenue Growth
- GTEC N/A
- ABVC N/A
- 52 Week Low
- GTEC $1.17
- ABVC $0.40
- 52 Week High
- GTEC $2.94
- ABVC $1.73
- Technical
- Relative Strength Index (RSI)
- GTEC 58.33
- ABVC 68.65
- Support Level
- GTEC $1.57
- ABVC $0.65
- Resistance Level
- GTEC $2.16
- ABVC $1.40
- Average True Range (ATR)
- GTEC 0.17
- ABVC 0.10
- MACD
- GTEC 0.10
- ABVC 0.05
- Stochastic Oscillator
- GTEC 51.84
- ABVC 62.66
About GTEC Greenland Technologies Holding Corporation
Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.